Synapse Open Synapse
Biology

Blackstone bets $1.5B on Pfizer’s obesity drug

BioPharma Dive · · 2 min read

The deal will support a sprawling Phase 3 program for a monthly GLP-1 shot Pfizer acquired by winning a bidding war for the drug’s previous owner, Metsera.

Latest from BioPharma Dive